Dandrit ‘s technique is based on Dendritic Cells, garland science made this easy-to-understand youtube video on the development of Dendritic Cells
http://www.youtube.com/watch?v=ZuccruG_79M
this stops at where the T-cells enters :)…
but don’t despair I’ve found another from KhanAcademy.org on the cytotoxic T-cells http://www.youtube.com/watch?v=xaz5ftvZCyI&feature=related (these are the cells that attack cancer-cells)
So far the only FDA approved vaccine is Provenge by Dendreon
http://www.youtube.com/watch?v=MTSc-hXxL3I
So far no video has been made on Dandrit’s MelCancerVac – lets hope a cash-infusion will change that – untill tehn we will have to make do with this written explanation of the process http://dandrit.dk/technology/vaccine-platform
Dendreon (DNDN) faces competition from other large companies such as Johnson/Johnson – here is an interesting contrarian article about the progress of J&J's Zytiga …. http://seekingalpha.com/article/642161-asco-data-…
The overall conclusion from this catfight is that cancer vaccine will be a focus area. I've no doubt that this will eventually mean that Dandrit will be swallowed by one of the major players.
Based on the fact that Dendreon seems to have most to gain by keeping cometitors out of the market taht they see as theirs (being first movers) I see clear advantages for Dendreon by aquiring Dandrit